Follow
Mohammed A. Omair
Mohammed A. Omair
Rheumatologist and Professor, Division of Rheumatology, King Saud University, Riyadh, Saudi Arabia
Verified email at ksu.edu.sa
Title
Cited by
Cited by
Year
Guidance on noncorticosteroid systemic immunomodulatory therapy in noninfectious uveitis: Fundamentals Of Care for UveitiS (FOCUS) initiative
AD Dick, JT Rosenbaum, HA Al-Dhibi, R Belfort Jr, AP Brézin, SP Chee, ...
Ophthalmology 125 (5), 757-773, 2018
2302018
Low bone density in systemic sclerosis. A systematic review
MA Omair, C Pagnoux, H McDonald-Blumer, SR Johnson
The Journal of rheumatology 40 (11), 1881-1890, 2013
1082013
Safety and effectiveness of mycophenolate in systemic sclerosis. A systematic review
MA Omair, A Alahmadi, SR Johnson
PLoS One 10 (5), e0124205, 2015
902015
Effect of gastrointestinal manifestations on quality of life in 87 consecutive patients with systemic sclerosis
MA Omair, P Lee
The Journal of rheumatology 39 (5), 992-996, 2012
682012
Medication adherence, depression and disease activity among patients with systemic lupus erythematosus
N Alsowaida, M Alrasheed, A Mayet, A Alsuwaida, MA Omair
Lupus 27 (2), 327-332, 2018
632018
Impact of COVID‐19 outbreak on rheumatic patients’ perceptions and behaviors: A cross‐sectional study
LM Hassen, IA Almaghlouth, IM Hassen, MH Daghestani, AA Almohisen, ...
International journal of rheumatic diseases 23 (11), 1541-1549, 2020
482020
Adaptation of the 2015 American College of Rheumatology treatment guideline for rheumatoid arthritis for the Eastern Mediterranean Region: an exemplar of the GRADE Adolopment
A Darzi, M Harfouche, T Arayssi, S Alemadi, KA Alnaqbi, H Badsha, ...
Health and Quality of Life Outcomes 15, 1-13, 2017
412017
Long-term safety and effectiveness of tumour necrosis factor inhibitors in systemic sclerosis patients with inflammatory arthritis
MA Omair, V Phumethum, SR Johnson
Clinical and Experimental Rheumatology-Incl Supplements 30 (2), S55, 2012
402012
Bone disease in systemic sclerosis: outcomes and associations
MA Omair, H McDonald-Blumer, SR Johnson
Clin Exp Rheumatol 32 (6 Suppl 86), S28-32, 2014
292014
Prevalence of HLA-B27 in the general population and in patients with axial spondyloarthritis in Saudi Arabia
MA Omair, FK AlDuraibi, MK Bedaiwi, S Abdulaziz, W Husain, ...
Clinical Rheumatology 36, 1537-1543, 2017
262017
Incidence of tuberculosis in people living with the human immunodeficiency virus in Saudi Arabia
MA Omair, AA Al-Ghamdi, AA Alrajhi
The International Journal of Tuberculosis and Lung Disease 14 (5), 600-603, 2010
182010
Prevalence of complementary and alternative medicine use among rheumatoid arthritis patients in Saudi Arabia
AM Almuhareb, TM Alhawassi, AA Alghamdi, MA Omair, H Alarfaj, ...
Saudi Pharmaceutical Journal 27 (7), 939-944, 2019
172019
Recommendations for the management of rheumatoid arthritis in the Eastern Mediterranean region: an adolopment of the 2015 American College of Rheumatology guidelines
T Arayssi, M Harfouche, A Darzi, S Al Emadi, K A. Alnaqbi, H Badsha, ...
Clinical rheumatology 37, 2947-2959, 2018
172018
Rituximab in a patient with ankylosing spondylitis with demyelinating disease: a case report and review of the literature
MA Omair, KA Alnaqbi, P Lee
Clinical rheumatology 31, 1259-1261, 2012
172012
Awareness and misconceptions of female students in King Saud University on systemic lupus erythematosus
MA Omair, SM Al Ohali, FA Abdulkarim, HA Madhi, LA Alghamdi
Rheumatology (Sunnyvale) 5 (03), 165, 2015
162015
Abatacept enhances blood regulatory B cells of rheumatoid arthritis patients to a level that associates with disease remittance
MF Alenazy, F Saheb Sharif-Askari, MA Omair, MS El-Wetidy, MA Omair, ...
Scientific Reports 11 (1), 5629, 2021
152021
Survey on management strategies of rheumatoid arthritis in Saudi Arabia: a Saudi Society for Rheumatology Initiative
MA Omair, MA Omair, H Halabi
International Journal of Rheumatic Diseases 20 (9), 1185-1192, 2017
152017
Interleukin-6 inhibition
E Keystone, MA Omair
Rheumatology: Sixth Edition, 485-491, 2015
152015
Effectiveness and adverse effects of anakinra in treatment of rheumatoid arthritis: a systematic review.
MK Bedaiwi, I Almaghlouth, MA Omair
European Review for Medical & Pharmacological Sciences 25 (24), 2021
142021
Adverse effects of selected markers on the metabolic and endocrine profiles of obese women with and without PCOS
MH Daghestani, MH Daghestani, A Warsy, A El-Ansary, MA Omair, ...
Frontiers in Endocrinology 12, 665446, 2021
142021
The system can't perform the operation now. Try again later.
Articles 1–20